ANMB Examinees' Poster Presentation 1 (Walking)

[EPP1-01] Bevacizumab radioimmunotherapy (RIT) in triple-negative breast cancer (TNBC) xenograft

Ryan Yudistiro¹、Hirofumi Hanaoka²、Natsumi Katsumata¹、Aiko Yamaguchi²、Yoshito Tsushima¹ (1.Department of Diagnostic Radiology and Nuclear Medicine, Gunma University、2.Dept of Bioimaging Information Analysis, Gunma University Graduate School of Medicine)